Buspirone vs SSRIs for Anxiety: FDA Approvals, Evidence and Side Effects

Both buspirone and several SSRIs are FDA-approved for anxiety, but they are not interchangeable. Buspirone is approved for anxiety disorders and the short-term relief of anxiety symptoms, and its trials were run in people whose diagnosis roughly corresponds to generalized anxiety disorder (GAD). Among SSRIs, escitalopram and paroxetine carry FDA approval for GAD, and SSRIs also have approvals for panic disorder, social anxiety disorder, OCD and PTSD that buspirone lacks.

NICE guidance names an SSRI as the first medication to offer for GAD, with another SSRI or an SNRI such as venlafaxine or duloxetine as the next step. Buspirone is an option prescribers may consider when an SSRI is not tolerated, not wanted, or not enough on its own. Neither is taken "as needed," and neither is a benzodiazepine. The choice belongs to you and your prescriber, based on your diagnosis, other conditions, other medicines and what side effects matter most to you.

Buspirone and SSRIs at a glance

How each one works and what to expect

Buspirone is not chemically or pharmacologically related to benzodiazepines, and its exact mechanism is unknown. It does not block benzodiazepine withdrawal, so someone coming off a benzodiazepine cannot simply substitute buspirone; the label advises withdrawing the earlier drug gradually first. It is less sedating than other anxiolytics and does not usually cause significant functional impairment, though the label still advises caution with driving until you know how it affects you.

Buspirone has to be built up. The label starts with a low divided dose and allows small increases every few days, and MedlinePlus notes it may take several weeks to reach a dose that works for you. Bioavailability changes with food, which is why the label asks that it be taken the same way each time.

SSRIs also work gradually. NICE's anxiety guideline tells prescribers to explain that the full anxiety-reducing effect develops over a week or more, and that treatment should continue after remission to avoid relapse. Early on, some people notice more anxiety, agitation or sleep trouble, which NICE describes as activation and asks prescribers to warn about. The practice's article on SSRI activation and anxiety covers that early phase.

What the evidence says

Buspirone

A Cochrane review of 36 trials found that azapirones, the class that includes buspirone, were better than placebo for GAD, with about 4.4 people needing treatment for one additional person to improve on a global rating. The same review found azapirones may be less effective than benzodiazepines, could not conclude whether they were better than antidepressants or psychotherapy, and noted that most studies lasted only four to nine weeks. Side effects were mild in the buspirone groups, and the reviewers found it useful particularly for people who had not been on a benzodiazepine.

The label is candid about the gaps: effectiveness beyond three to four weeks was not demonstrated in controlled trials, although one study treated 264 patients for a year without ill effect, so prescribers are asked to reassess periodically.

SSRIs and SNRIs

NICE recommends an SSRI as the first drug for GAD when someone chooses medication, suggests sertraline first on cost grounds, and moves to another SSRI or an SNRI if that does not work. In the United States, escitalopram and paroxetine are FDA-approved for GAD, as are the SNRIs duloxetine and extended-release venlafaxine; sertraline's use for GAD is off-label in the US. For panic disorder, NICE says antidepressants should be the only medication class used in longer-term management, and buspirone has no FDA indication for panic disorder or social anxiety disorder. If panic is your main problem, see panic disorder treatment options.

Side effects and safety compared

Buspirone has important interactions of its own. Strong CYP3A4 inhibitors such as itraconazole raised buspirone concentrations many times over in a study, and the label recommends a much lower dose if they must be combined. It must not be combined with an MAOI antidepressant or started within 14 days of one.

The SSRI boxed warning is about suicidal thoughts and behaviors in children, teens and young adults during short-term studies, and it asks prescribers to monitor everyone starting an antidepressant for worsening and new suicidal thoughts. NICE adds that people under 30 starting an SSRI or SNRI for anxiety should be seen within a week and monitored weekly for the first month.

If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

Using them together

Buspirone is sometimes added to an SSRI when anxiety improves only partly. The combination is not forbidden, but both drugs are serotonergic, and the buspirone label lists serotonin syndrome as a risk that is higher with other serotonergic drugs, so your prescriber will watch for agitation, fever, sweating, tremor, muscle rigidity or diarrhea. Evidence for the combination in anxiety is thinner than for either drug alone; the Cochrane review did not establish how buspirone compares with antidepressants, let alone in combination. For depression, adding a second medicine is a separate decision covered in antidepressant augmentation options.

Who tends to fit which option

These are common reasons a prescriber leans one way, not rules:

• GAD with depression, panic attacks, social anxiety, OCD or PTSD alongside it: an SSRI or SNRI usually covers more ground, because those conditions are approved SSRI uses and not buspirone uses.
• GAD alone, with troublesome sexual side effects from SSRIs in the past: buspirone is often discussed.
• A history of bipolar disorder: SSRIs need extra caution because of the mania warning.
• Coming off a benzodiazepine: buspirone will not ease withdrawal, so the taper is handled separately.
• A child with GAD: escitalopram and duloxetine have pediatric GAD approvals, while buspirone did not beat placebo in pediatric trials.
• Taking blood thinners or regular NSAIDs: SSRI bleeding risk becomes part of the conversation.
• Chronic pain alongside anxiety: duloxetine, an SNRI, is also FDA-approved for diabetic nerve pain, fibromyalgia and chronic musculoskeletal pain, which can make it a two-for-one option worth asking about.
• A strong preference to avoid medication: CBT or applied relaxation is an equally valid choice for GAD under NICE guidance, and medication can be offered if therapy does not help.

Choosing between individual SSRIs is its own question; see sertraline vs escitalopram and venlafaxine vs duloxetine for the SNRIs.

If the first medicine does not work

NICE asks prescribers to review effectiveness and side effects every 2 to 4 weeks during the first 3 months of treatment for GAD, then every 3 months. If sertraline or another first SSRI does not help, the next step it describes is a different SSRI or an SNRI, weighing withdrawal tendencies (particularly with paroxetine and venlafaxine), side effects, interactions and overdose risk. If side effects appear early, the options it lists are closer monitoring when they are mild, a dose reduction, or stopping and moving to another drug or to a psychological treatment, according to your preference.

When a medicine does work, NICE advises continuing it for at least a year because the likelihood of relapse is high. That is a reason to choose a medicine you can tolerate over the long run, not only one that helps in the first month. If you are moving from an SSRI to buspirone or the reverse, the timing and any overlap are decisions for your prescriber; the general principles are covered in switching antidepressants.

Special situations

• Liver or kidney disease: the buspirone label says it cannot be recommended for people with severe liver or kidney impairment.
• Older adults: NICE asks prescribers to weigh the higher bleeding risk with SSRIs, particularly in older people and those taking NSAIDs or aspirin, and to consider a stomach-protecting drug in those cases. SSRIs can also lower sodium levels.
• Breastfeeding: the buspirone label advises avoiding it in nursing women if clinically possible.
• Pregnancy: the buspirone label notes that adequate human studies have not been done. Plans are best discussed before conception; see psychiatric medications during pregnancy.
• Taking an MAOI, linezolid or intravenous methylene blue: buspirone is contraindicated in these situations because of serotonin syndrome risk, and with MAOI antidepressants also high blood pressure.

Common mistakes

• Judging buspirone after a few days at the starting dose, before it has been adjusted as the label describes.
• Taking it sometimes with meals and sometimes on an empty stomach, which changes how much is absorbed.
• Stopping an SSRI abruptly when it seems not to work, rather than asking about a gradual reduction.
• Expecting buspirone to replace a benzodiazepine overnight.
• Not mentioning over-the-counter pain relievers, supplements or migraine medicines, which can matter for bleeding or serotonin syndrome risk.

Where therapy fits

Medication is not the only first step. NICE asks clinicians to base the choice between a high-intensity psychological treatment and medication for GAD on the person's preference, because neither has been shown to be better, and it names CBT and applied relaxation as the psychological options. If one approach does not help, NICE recommends offering the other. The full menu, including therapy, is compared in anxiety treatment options compared, and the practice's page on CBT for anxiety describes what that work looks like.

What the evidence does not tell you

• Most buspirone trials were short, so long-term benefit is less well documented than the label's short-term results.
• No test predicts whether you will respond better to buspirone or to an SSRI.
• Head-to-head comparisons between buspirone and SSRIs are limited; the Cochrane reviewers could not conclude which is better.
• Guideline preferences partly reflect cost and the breadth of conditions SSRIs treat, not only effect size.

Questions to ask your prescriber

• Is my diagnosis GAD, panic disorder, social anxiety or something else, and does that change which medicine fits?
• Is the medicine you are suggesting FDA-approved for my diagnosis, or off-label?
• How long should I give it before we judge whether it works, and when will we check in?
• Which of my other medicines, supplements or foods interact with it?
• What side effects should make me call you, and what should I do if anxiety spikes in the first weeks?
• If this helps, how long would I stay on it, and how would we stop it later?

Never start, stop or change the dose of either medicine on your own; changes go through your prescriber.

How this practice approaches anxiety medication

Ongoing care at the practice includes psychiatric evaluation and medication management, psychotherapy including CBT and DBT, coaching, and nutrition and lifestyle psychiatry. The team includes psychiatrists, psychiatric nurse practitioners and psychotherapists, so medication and therapy can be planned together. You can read about medication management at the practice, and individual care starts with the Patient Interest Form. More decision guides are in Choosing Psychiatric Care.

Frequently asked questions

Can I take buspirone only when I feel anxious?

It is not designed for that. Buspirone is taken every day on a schedule, and it can take weeks to reach a dose that works. If you need relief for occasional spikes, talk with your prescriber about the options and their trade-offs.

Is buspirone addictive?

Buspirone is not a controlled substance, and in studies it showed no evidence of tolerance or physical or psychological dependence. The label still asks prescribers to watch for misuse in people with a history of substance problems.

Does buspirone cause weight gain or sexual side effects?

Neither is among the commonly observed side effects on the label, which lists dizziness, nausea, headache, nervousness, lightheadedness and excitement. Weight gain appears only as an infrequent event. Individual experiences vary, so report anything that bothers you.

Why did my prescriber suggest an SSRI when I only have anxiety, not depression?

Several SSRIs are FDA-approved for anxiety disorders, including GAD, panic disorder and social anxiety disorder, and guidelines such as NICE's list an SSRI as the first medication choice for GAD.

Can I drink alcohol on buspirone?

Studies did not show that buspirone increases alcohol-related impairment, but the label still advises avoiding the combination. See psychiatric medications and alcohol for more.

Is buspirone safe in pregnancy?

The label says adequate, well-controlled studies in pregnancy have not been done and that it should be used in pregnancy only if clearly needed. Discuss pregnancy plans with your prescriber before starting or changing any anxiety medicine.

Sources

1. Buspirone hydrochloride tablets prescribing information. DailyMed / U.S. FDA label (Advagen Pharma), 2026. dailymed.nlm.nih.gov
2. LEXAPRO (escitalopram) prescribing information. DailyMed / U.S. FDA label (Allergan), 2023. dailymed.nlm.nih.gov
3. Paroxetine tablets prescribing information. DailyMed / U.S. FDA label (RemedyRepack), 2026. dailymed.nlm.nih.gov
4. Duloxetine delayed-release capsules prescribing information. DailyMed / U.S. FDA label (Alembic), 2026. dailymed.nlm.nih.gov
5. EFFEXOR XR (venlafaxine extended-release) prescribing information. DailyMed / U.S. FDA label (Viatris), 2023. dailymed.nlm.nih.gov
6. ZOLOFT (sertraline) prescribing information. DailyMed / U.S. FDA label (Viatris), 2023. dailymed.nlm.nih.gov
7. Azapirones for generalized anxiety disorder. Cochrane Database of Systematic Reviews (PubMed 16856115), 2006. pubmed.ncbi.nlm.nih.gov
8. Generalised anxiety disorder and panic disorder in adults: management (CG113), Recommendations. National Institute for Health and Care Excellence (NICE), 2011, updated 2020. nice.org.uk
9. Buspirone: MedlinePlus Drug Information. U.S. National Library of Medicine, 2026. medlineplus.gov

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.